Navigation Links
Global Biotechnology Market Worth $604.40 Billion by 2020: Grand View Research, Inc

San Francisco, California (PRWEB) July 28, 2014

The global market for biotechnology is expected to reach USD 604.40 billion by 2020, according to a new study by Grand View Research, Inc. Increasing application scope coupled with the rising demand for effective vaccines and drugs in an attempt to improve healthcare access to patients with unmet medical needs is expected to drive market demand over the next six years. In addition, the need to enhance agricultural productivity via the use of genetically engineered seeds is expected to serve this market as a driver.

Biopharmacy dominated the overall market, accounting for over 60% of the total revenue in 2013. High costs associated with the drug discovery process coupled with increasing healthcare expenditures in emerging markets such as India, China and Brazil are some of the factors augmenting biopahrmacy growth. Growing popularity of contract research outsourcing (CRO) services in an attempt to curb manufacturing and R&D costs are expected to drive bioservices demand, which is expected to be the fastest growing application market for biotechnology..

The report “Biotechnology (Biopharmacy, Bioservices, Bioagriculture, Bioindustrial, Fermentation, DNA sequencing, Tissue Engineering, Regeneration) Market Analysis And Segment Forecasts To 2020,” is available now to Grand View Research customers and can also be purchased directly at

Request Free Sample of This Report @

Further key findings from the study suggest:

  • North America was the largest regional market, accounting for over 40% of global revenue in 2013, with growth being driven by the presence of sophisticated healthcare infrastructure, high patient awareness levels and healthcare expenditure.
  • Asia Pacific is expected to register the fastest CAGR of 14.8% during the forecast period owing to the presence of untapped opportunities in emerging markets such as India and China.
  • Tissue engineering and regeneration technology dominated the market in terms of revenue share in 2013 at 32.5% on account of the rising demand for regenerative medicine.
  • Key industry participants include Novo Nordisk, Amgen, Gilead Sciences, Celgene, Biogen Idic, Teva Pharmaceutical Industries, Merck KGaA, CSL, Regeneron, Alexion Pharmaceuticals, Shire PLC, Vertex Pharmaceuticals, BioMarin Pharmaceutical, Elan, Actelion, Onyx Pharmaceuticals, Dr. Reddy’s Laboratories, Seattle Genetics, Alkermes, Ariad Pharmaceuticals, Cubist Pharmaceuticals, United Therapeutics, Ipsen Group and DiaSorin.

Browse All Reports of This Category @

For the purpose of this study, Grand View Research has segmented the global biotechnology market on the basis of application and region:

  •      Biotechnology Application Outlook
            • Medical Gases
            • BioPharmacy
            • BioServices
            • BioAgriculture
            • BioIndustrial
  •      Biotechnology Technology Outlook
            • Fermentation
            • Tissue engineering and Regeneration
            • PCR Tehnology
            • Nanobiotechnology
            • Chromatography Market
            • DNA Sequencing
            • Cell Based Assay
            • Others
  •      Biotechnology Regional Outlook
            • North America
            • Europe
            • Asia Pacific
            • RoW

Browse All Upcoming Reports of Grand View Research @

About Grand View Research

Grand View Research, Inc. is a market research and consulting company that provides off-the-shelf, customized research reports and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and energy. With a deep-seated understanding of varied business environments, Grand View Research provides strategic objective insights. For more information, visit

Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415-349-0058

Upcoming Reports:

Maritime Security Market Analysis, Market Size, Application Analysis, Regional Outlook, Competitive Strategies And Forecasts, 2014 To 2020 -

D-Dimer Market Analysis, Market Size, Application Analysis, Regional Outlook, Competitive Strategies And Forecasts, 2014 To 2020 -

Read the full story at

Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related biology technology :

1. Global Particle Size Analysis Market 2014-2018
2. Ischemic Stroke and Cerebral Stroke Global Clinical Trials Review H2, 2014: MarketResearchReports.Biz
3. Global Metabolomics Market 2014-2018: Key Vendors are Agilent, Bio-Rad, Bruker, Human Metabolome and Metabolon
4. Biological Drugs Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020
5. Global Cell Culture Market 2014-2018: Key Vendors are Becton, Dickinson and Co, EMD, GE Healthcare, Lonza Group, Sigma Aldrich and Thermo Fisher Scientific
6. Global Genomics and Proteomics Analytical Instruments Market 2014-2018: Key Vendors are Agilent, Bio-Rad , F. Hoffmann, La Roche, Illumina, PerkinElmer and Thermo Fisher Scientific
7. Potassium Sulphate Market & SHMP Industry 2014 (Global, China) Analysis Now Available at
8. Nuclear Energy Market: Global Industry Analysis, Size, Share, Analysis, Growth and Forecast 2013 - 2019
9. Global Cell Culture Market to Grow at 10.27% CAGR by 2018 Forecasts a New Research Report
10. Global Graphene Manufacturing Leader, Graphene Frontiers, Receives Series Seed B Funding To Assure Production Of The Next Generation Of Biological And Chemical Sensor Technology
11. Global & USA Cancer Biomaker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends, and Pipeline Analysis) - Market Size, Trends, and Forecasts A
Post Your Comments:
(Date:11/25/2015)... PUNE, India , November 26, 2015 /PRNewswire/ ... The Global Biobanking Market 2016 - 2020 ... biobanks by maintaining integrity and quality in long-term ... and enabling long-term cost-effectiveness. Automation minimizes manual errors ... improves the technical efficiency. Further, it plays a ...
(Date:11/25/2015)... 2 nouvelles études permettent d ... différences entre les souches bactériennes retrouvées dans la plaque ... humains . Ces recherches  ouvrent une nouvelle ... charge efficace de l,un des problèmes de santé ... .    --> 2 nouvelles études permettent d ...
(Date:11/25/2015)... and HOLLISTON, Mass. , Nov. 25, ... HART ), a biotechnology company developing bioengineered organ ... Jim McGorry will present at the LD Micro ... at 2:30 p.m. PT. The presentation will be webcast ... days. Management will also be available at the conference ...
(Date:11/25/2015)... , Nov. 25, 2015 /PRNewswire/ - Aeterna Zentaris Inc. ... its business and prospects remain fundamentally strong and ... (zoptarelin doxorubicin) recently received DSMB recommendation to continue ... following review of the final interim efficacy and ... Primary Endpoint in men with heavily pretreated castration- ...
Breaking Biology Technology:
(Date:11/17/2015)... November 17, 2015 Paris ... --> Paris from 17 th ... the biometrics innovation leader, has invented the first combined scanner ... the same scanning surface. Until now two different scanners were ... scanner can capture both on the same surface. This ...
(Date:11/12/2015)... BOSTON , Nov. 12, 2015  A golden ... for Duchenne muscular dystrophy (DMD) has provided a new ... Boston Children,s Hospital, the Broad Institute of MIT and ... Brazil . Cell, ... some dogs "escape" the disease,s effects. The Boston Children,s ...
(Date:11/10/2015)... 2015 About signature verification ... to identify and verify the identity of an ... the secure and accurate method of authentication and ... individual because each individual,s signature is highly unique. ... dynamic signature of an individual is compared and ...
Breaking Biology News(10 mins):